PNEUMOCOCCAL DISEASE

This study tested a new vaccine called V116 in 313 adults with HIV to see if it can safely protect them from pneumococcal disease (a serious lung infection). The vaccine aims to trigger a strong immune response against 21 types of the bacteria. Researchers compared it to existing…

This study tested a new vaccine (20vPnC) that protects against 20 types of pneumonia-causing bacteria. About 541 healthy infants in India and Taiwan received either the new vaccine or an existing one over 4 doses. Researchers checked for side effects and measured immune responses…

This study tested a new 20-valent pneumococcal vaccine (20vPnC) in 400 Chinese adults aged 50 and older who had never received a pneumonia vaccine. The goal was to see if it is safe and triggers a strong immune response compared to the current 13-valent vaccine. Participants were…

This study tested a new pneumococcal vaccine in 225 healthy toddlers aged 12 to 15 months. The goal was to see if the vaccine is safe and triggers a strong immune response. Participants received either one or two doses and were monitored for side effects like redness, fever, and …

This study tested a new vaccine called V116 in over 1,400 adults aged 50 and older to see if it could prevent pneumococcal disease, which can cause pneumonia and other serious infections. The vaccine was compared to the current standard vaccine (PPSV23). Researchers checked how w…